CAS 2095432-55-4

Fórmula: C23H30N2O2

InChI: InChI=1S/C23H30N2O2/c1-17-8-10-18(11-9-17)14-25(23(2,3)4)15-19(26)16-27-22-7-5-6-21-20(22)12-13-24-21/h5-13,19,24,26H,14-16H2,1-4H3

Chave InChI: BNRANURXPKRRKP-UHFFFAOYSA-N

SMILES: CC1=CC=C(C=C1)CN(CC(COC2=CC=CC3=C2C=CN3)O)C(C)(C)C

SR-18292

CAS: 2095432-55-4

SR-18292

Fórmula: C₂₃H₃₀N₂O₂

Pureza: ≥98%

Peso molecular: 366.5

Ref: 54-BUP09945

1-((1H-Indol-4-yl)oxy)-3-(tert-butyl(4-methylbenzyl)amino)propan-2-ol

CAS: 2095432-55-4

Fórmula: C₂₃H₃₀N₂O₂

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 366.4965

Ref: IN-DA01EB1J

SR-18292

CAS: 2095432-55-4

1-((1H-Indol-4-yl)oxy)-3-(tert-butyl(4-methylbenzyl)amino)propan-2-ol

Fórmula: C₂₃H₃₀N₂O₂

Pureza: 99% (HPLC)

Peso molecular: 366.5

Ref: IN-DG765288

SR-18292

CAS: 2095432-55-4

SR-18292 inhibits PGC-1α, enhances acetylation, lowers gluconeogenesis, and cuts hepatic glucose production.

Fórmula: C₂₃H₃₀N₂O₂

Pureza: 99.14% - 99.91%

Cor e Forma: Solid

Peso molecular: 366.4965

Ref: TM-T4353

SR 18292

Produto Controlado

CAS: 2095432-55-4

Fórmula: C₂₃H₃₀N₂O₂

Cor e Forma: Neat

Peso molecular: 366.5

Ref: TR-S684483

SR 18292

CAS: 2095432-55-4

Inhibitor of transcriptional coactivator PGC-1a; anti-diabetic agent

Fórmula: C₂₃H₃₀N₂O₂

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 366.5 g/mol

Ref: 3D-FS165261